Publikationen

Kubinski, M., Beicht, J., Gerlach, T., Aregay, A., Osterhaus, A. D. M. E., Tscherne, A., Sutter, G., Prajeeth, C. K., & Rimmelzwaan, G. F. (2024). Immunity to tick-borne encephalitis virus NS3 protein induced with a recombinant modified vaccinia virus Ankara fails to afford mice protection against TBEV infection. Vaccines, 12(1), Article 105. https://doi.org/10.3390/vaccines12010105
Details anzeigen

Leroux-Roels, I., Prajeeth, K. C., Aregay, A., Nair, N., Rimmelzwaan, G. F., Osterhaus, A. D. M. E., Kardinahl, S., Pelz, S., Bauer, S., D’Onofrio, V., Alhatemi, A., Jacobs, B., De Boever, F., Porrez, S., Waerlop, G., Punt, C., Hendriks, B., von, van de, et al. (2024). Safety and immunogenicity of the live-attenuated hRVFV-4s vaccine against rift valley fever in healthy adults: a dose-escalation, placebo-controlled, first-in-human, phase 1 randomised clinical trial. The Lancet: Infectious Diseases, 24(11), 1245–1253. https://doi.org/10.1016/S1473-3099(24)00375-X
Details anzeigen

Prajeeth, C. K., Zdora, I., Saletti, G., Friese, J., Gerlach, T., Wilken, L., Beicht, J., Kubinski, M., Puff, C., Baumgärtner, W., Kortekaas, J., Wichgers Schreur, P. J., Osterhaus, A. D. M. E., & Rimmelzwaan, G. F. (2024). Immune correlates of protection of the four-segmented Rift Valley fever virus candidate vaccine in mice. Emerging Microbes & Infections, 13, Article 2373313. https://doi.org/10.1080/22221751.2024.2373313
Details anzeigen

Beicht, J., Kubinski, M., Zdora, I., Puff, C., Biermann, J., Gerlach, T., Baumgärtner, W., Sutter, G., Osterhaus, A., Prajeeth, C. K., & Rimmelzwaan, G. F. (2023). Induction of humoral and cell-mediated immunity to the NS1 protein of TBEV with recombinant Influenza virus and MVA affords partial protection against lethal TBEV infection in mice. Frontiers in Immunology, 14, Article 1177324. https://doi.org/10.3389/fimmu.2023.1177324
Details anzeigen

Kubinski, M., Beicht, J., Zdora, I., Biermann, J., Puff, C., Gerlach, T., Tscherne, A., Baumgärtner, W., Osterhaus, A., Sutter, G., Prajeeth, C. K., & Rimmelzwaan, G. F. (2023). A recombinant modified vaccinia virus Ankara expressing prME of tick-borne encephalitis virus affords mice full protection against TBEV infection. Frontiers in Immunology, 14, Article 1182963. https://doi.org/10.3389/fimmu.2023.1182963
Details anzeigen

Kubinski, M., Beicht, J., Zdora, I., Saletti, G., Kircher, M., Petry-Gusmag, M., Steffen, I., Puff, C., Jung, K., Baumgärtner, W., Rimmelzwaan, G. F., Osterhaus, A. D. M. E., & Prajeeth, C. K. (2023). Cross-reactive antibodies against Langat virus protect mice from lethal tick-borne encephalitis virus infection. Frontiers in Immunology, 14, Article 1134371. https://doi.org/10.3389/fimmu.2023.1134371
Details anzeigen

Nair, N., Osterhaus, A., Rimmelzwaan, G., & Prajeeth, C. K. (2023). Rift Valley fever virus: infection, pathogenesis and host immune responses. Pathogens, 12(9), Article 1174. https://doi.org/10.3390/pathogens12091174
Details anzeigen

Pilchová, V., Prajeeth, C. K., Jendrny, P., Twele, F., Meller, S., Pink, I., Volk, H. A., Osterhaus, A., von Köckritz-Blickwede, M., & Schulz, C. (2023). β-Propiolactone (BPL)-inactivation of SARS-Co-V-2: in vitro validation with focus on saliva from COVID-19 patients for scent dog training. In 32nd Annual Meeting of the Society of Virology: abstracts (P 267).
Details anzeigen

Pilchová, V., Prajeeth, C. K., Jendrny, P., Twele, F., Meller, S., Pink, I., Fathi, A., Addo, M. M., Volk, H. A., Osterhaus, A., Köckritz-Blickwede, M. v., & Schulz, C. (2023). β-Propiolactone (BPL)-inactivation of SARS-Co-V-2: in vitro validation with focus on saliva from COVID-19 patients for scent dog training. Journal of Virological Methods, 317, 114733. https://doi.org/10.1016/j.jviromet.2023.114733
Details anzeigen

Wilken, L., Stelz, S., Agac, A., Sutter, G., Prajeeth, C. K., & Rimmelzwaan, G. F. (2023). Recombinant modified vaccinia virus Ankara expressing a glycosylation mutant of dengue virus NS1 induces specific antibody and T-cell responses in mice. Vaccines, 11(4), Article 714. https://doi.org/10.3390/vaccines11040714
Details anzeigen

Guilfoyle, K., Mirolo, M., van, van der, Lombardo, M. S., Störk, T., Rimmelzwaan, G., Ludlow, M., & Osterhaus, A. (2025). Susceptibility of calf lung slice cultures to H5N1 influenza virus. Emerging Microbes & Infections, 14(1), Article 2432368. https://doi.org/10.1080/22221751.2024.2432368
Details anzeigen

Gregor, K. M., Mirolo, M., Brandes, F., Jesse, S. T., Kaiser, F., Verspohl, J., Wölfl, S., Osterhaus, A. D. M. E., Baumgärtner, W., Ludlow, M., & Beineke, A. (2024). Fatal feline leukemia virus-associated enteritis in a wild Eurasian lynx (Lynx lynx) in Germany. Biology, 13(12), Article 997. https://doi.org/10.3390/biology13120997
Details anzeigen

Hetterich, J., Mirolo, M., Kaiser, F., Ludlow, M., Reineking, W., Zdora, I., Hewicker-Trautwein, M., Osterhaus, A. D. M. E., & Pees, M. (2024). Concurrent detection of a papillomatous lesion and sequence reads corresponding to a member of the family Adintoviridae in a bell’s hinge-back tortoise (Kinixys belliana). Animals, 14(2), Article 247. https://doi.org/10.3390/ani14020247
Details anzeigen

Kühl, B., Mirolo, M., Rubio-Garcìa, A., Wohlsein, P., Puff, C., Ludlow, M., Osterhaus, A., Baumgärtner, W., & Beineke, A. (2024). Phocines Hepatovirus: erster Nachweis bei Seehunden in Nordeuropäischen Gewässern. In 67. Jahrestagung der Fachgruppe Pathologie der Deutschen Veterinärmedizinischen Gesellschaft (P13). https://doi.org/10.1055/s-0044-1787379
Details anzeigen

Mirolo, M., Roi, M. d. l., von Dörnberg, K., Kaiser, F., Fayyad, A., Puff, C., Voigt, U., Siebert, U., Ludlow, M., Baumgärtner, W., & Osterhaus, A. (2024). Umatilla virus in zoo-dwelling cape penguins with hepatitis, Germany. Emerging Infectious Diseases, 30(12), 2643–2646. https://doi.org/10.3201/eid3012.240498
Details anzeigen

Pöpperl, P., Chludzinski, E., Stoff, M., Ludlow, M., Geffers, R., & Beineke, A. (2024). Hundeelend in der Titerplatte: In vitro-Infektion primärer Zielzellen des kaninen Staupevirus erlaubt Einblicke in Mechanismen der angeborenen Immunantwort. In Tierärztliche Praxis / K. Thieme. https://doi.org/10.1055/s-0044-1787336
Details anzeigen

Waldock, J., Cox, R. J., Engelhardt, O. G., Ascough, S., Osterhaus, A., Rimmelzwaan, G. F., Ludlow, M., Tregoning, J. S., McDonald, J. U., Buchholz, U. J., Jeeninga, R. E., Sande, C., & Chiu, C. (2024). Inno4Vac workshop report part 2: RSV-controlled human infection model (CHIM) strain selection and immune assays for RSV CHIM studies, November 2021, MHRA, UK. Influenza and Other Respiratory Viruses, 18(10), Article e70013. https://doi.org/10.1111/irv.70013
Details anzeigen

Wiese, L., Kolbe, S. M., Weber, M., Ludlow, M., & Christmann, M. (2024). Synthesis and biological evaluation of cleistocaltone A, an inhibitor of respiratory syncytial virus (RSV). Chemical Science, 15(26), 10121–10125. https://doi.org/10.1039/d4sc01897d
Details anzeigen

Agac, A., Kolbe, S. M., Ludlow, M., Osterhaus, A., Meineke, R., & Rimmelzwaan, G. F. (2023). Host responses to respiratory syncytial virus infection. Viruses, 15(10), Article 1999. https://doi.org/10.3390/v15101999
Details anzeigen

Gremmel, N. (2023). Hepatitis E virus: isolation of porcine virus strains and characterization of serum antibodies. https://nbn-resolving.org/urn:nbn:de:gbv:95-118707
Details anzeigen